New York, July 19, 2018: The Clinical Trial Imaging Market is Expected to Exceed more than US$ 981 Million by 2020.
The Global clinical trial imaging market is segmented on the lines of its products, modality, end users and regional. The products are further segmented into software and services. Based on services segmentation it covers into system and technology, reader service, operational imaging services and design consulting. The modality market is classified intoX ray, PET, CT, MRI, ultrasound, echo and others. The CT has the main share in the clinical trial imaging market. End users segmented into academic and government research institutes, medical devices manufacturers, biopharmaceutical companies, CROs and others.
The scope of the report includes a detailed study of global and regional markets Global clinical trial imaging market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BioClinica Inc, Cardiovascular Imaging Technologies, ICON plc, Biomedical Systems, Intrinsic Imaging LLC, PAREXEL International Corporation, VirtualScopic Inc and Prism Clinical Imaging. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
You Can Browse Full Report: https://www.marketresearchengine.com/clinical-trial-imaging-market
The major driving factors of global clinical trial imaging market are as follows:
- Rise in R&D spending
- Rising number of cros
- Development in the biotechnology and pharmaceutical Industries
The restraining factors of global clinical trial imaging market are as follows:
- High implementation charge of imaging systems
This report provides:
1) An overview of the global market for global clinical trial imaging market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for global clinical trial imaging market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The Global Clinical trial imaging Market has been segmented as below:
The Global Clinical trial imaging Market this market is segmented on the basis of Product Segment Analysis, Modality Analysis, End-user Analysis and Regional Analysis.
By Product Segment Analysis this market is segmented on the basis of Software, Service, System and technology, Reader service, Operational imaging services and Design consulting. By Modality Analysis this market is segmented on the basis of X ray, PET, CT, MRI, Ultrasound, Echo and Others. By End-user Analysis this market is segmented on the basis of Academic and government research institutes, Medical devices manufacturers, Biopharmaceutical companies, CROs and Others. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
Request Sample Report here: https://www.marketresearchengine.com/clinical-trial-imaging-market
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Clinical Trial Imaging Market, By Product and Service
7 Clinical Trial Imaging Market, By Modality
8 Clinical Trial Imaging Market, By End User
9 Clinical Trial Imaging Market, By Region
10 Competitive Landscape
11 Company Profiles
11.2 Bioclinica, Inc.
11.3 Parexel International Corporation
11.4 Icon PLC
11.5 Biomedical Systems Corporation
11.6 Biotelemetry, Inc.
11.7 Cardiovascular Imaging Technologies, LLC
11.8 Intrinsic Imaging LLC
11.9 Ixico PLC
11.10 Radiant Sage LLC
11.11 Worldcare Clinical, LLC
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States